Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Oral apixaban for the treatment of venous thromboembolism in cancer patients: results from the AMPLIFY trial.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Oral apixaban for the treatment of venous thromboembolism in cancer patients: results from the AMPLIFY trial.
Oral apixaban for the treatment of venous thromboembolism in cancer patients: results from the AMPLIFY trial. J Thromb Haemost. 2015 Dec; 13(12):2187-91.
View in:
PubMed
subject areas
Aged
Aged
Anticoagulants
Anticoagulants
Chi-Square Distribution
Chi-Square Distribution
Double-Blind Method
Double-Blind Method
Enoxaparin
Enoxaparin
Factor Xa Inhibitors
Factor Xa Inhibitors
Female
Female
Hemorrhage
Hemorrhage
Humans
Humans
Logistic Models
Logistic Models
Male
Male
Middle Aged
Middle Aged
Neoplasms
Neoplasms
Odds Ratio
Odds Ratio
Pyrazoles
Pyrazoles
Pyridones
Pyridones
Recurrence
Recurrence
Risk Factors
Risk Factors
Time Factors
Time Factors
Treatment Outcome
Treatment Outcome
Venous Thromboembolism
Venous Thromboembolism
Warfarin
Warfarin
authors with profiles
Gary E Raskob